The effort, called Sentinel Initiative,
will be the first time the FDA will have an opportunity to monitor
almost immediately how drugs are affecting the public. To do so, the
agency will mine databases of more than 20 million patients who receive
their drugs through Medicare. The idea, of course, is to catch side
effects that might otherwise go undetected for months or years.
Molecular and statistical genetic studies in 15 Finnish families have shown that there is a substantial genetic component in musical aptitude.
Musical aptitude was determined using three tests: a test for auditory structuring ability (Karma Music test), and the Seashore pitch and time discrimination subtests. The study represents the first systematic molecular genetic study that aims in the identification of candidate genes associated with musical aptitude.
File this under "Interesting if true" — or what scientists call "needs replication."
from Furious Seasons by
Thanks to CL Psych who flagged this issue the other day and posted one academic paper acknowledging that not only are there weird problems such as genital anesthesia–such a polite term–connected with anti-depressant use in some cases, but that the rate of sexual dysfunction on the happy pills isn’t very happy at all. In fact, it’s much higher than doctors have commonly assumed and than pharma companies have been willing to admit.
Dawdy — a fearless chronicler of others’ and his own experience with depression and antidepressants — notes that he himself experienced no sexual side-effects.
The Economist has a short but telling article on whether the so-called ‘autism epidemic’, occasionally touted in the media, may simply be a change in how developmental problems are diagnosed.
It covers a new study that did something really simple – it tracked down 38 people who, years ago, had been diagnosed with a delay in language and re-assessed them using the latest diagnostic interviews.